Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization  + (The author(s) declared the following poten … The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Ralph Muecke has had conference and travel expenses reimbursed and has received lecture fees from the pharmaceutical company biosyn-Arzneimittel GmbH to help run the study.n-Arzneimittel GmbH to help run the study.)
• Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients  + (The authors declare no competing interest.)
• Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology  + (The authors declare no conflict of interest.)
• Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?  + (The authors declared no conflict of interest.)
• Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study  + (The authors have declared no conflicts of interest.)
• Bossi et al. (2017): A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin  + (The authors have no conflict of interest to declare. F. Macci is a full-time employee of Helsinn. L. Michellini and F. Montanaro received financial support from Helsinn for the conduct of the study.)
• Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population?  + (The authors have no conflicts of interest related to this work.)
• Del Giglio (2013): Purified Dry Extract of Paullinia cupana (Guarana) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study  + (The authors report no conflicts of interest Preparation was produced by the author himself.)

• Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life  + (The authors report no conflicts of interest)

• Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects  + (The authors thank Dr. W. Schiess (Mucos Pharma, Geretsried) for his support in manuscript preparation.)
• Özdelikara et al. (2017): The Effect of Reflexology on Chemotherapy-induced Nausea, Vomiting, and Fatigue in Breast Cancer Patients  + (There are no conflicts of interest.)
• Su et al. (2004): Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms  + (Verum was donated by a commercial company)
• Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study  + (Verum was donated to the RCT.)
• Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial  + (Within the past three years, Dr. Khan has served as a consultant to Novartis Pharmaceutical Company, Inc. and Pfizer. Drs. Khan and Sharma have received during the past three years, via their institution)
• Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597  + (“Employment or Leadership Position: None; Consultant or Advisory Role: David H. Johnson, Peloton Therapeutics (C), Mirna Therapeutics (C) Stock Ownership: None; Honoraria: None; research; Expert Testimony: None; Patents: None Other Remuneration: None“)
• Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial  + („RM has had conference and travel expenses … „RM has had conference and travel expenses reimbursed and has received lecture fees from the pharmaceutical company biosyn-Arzneimittel GmbH, biosyn-Arzneimittel GmbH is not financing this manuscript. The other authors declare that they have no competing interests.“re that they have no competing interests.“)